Deanna L. Kirkpatrick

Davis Polk advised the underwriter in connection with the $39.3 million SEC-registered offering of 2,500,000 ordinary shares of Oxford Immunotec Global PLC. The ordinary shares are…

Davis Polk advised DXC Technology Company on its SEC-registered offering of $650 million aggregate principal amount of senior floating-rate notes due 2021.  DXC is an end-to-end IT…

Davis Polk advised DXC Technology Company in connection with its registered exchange offers of (i) up to $445.265 million aggregate principal amount of DXC’s new 4.45% senior notes due 2022…

Davis Polk advised the dealer manager on Ciena Corporation’s offer to exchange up to $350 million aggregate principal amount at maturity of outstanding 3.75% convertible senior notes…

Davis Polk advised the underwriters in connection with the SEC-registered offering of $1.5 billion aggregate principal amount of 2.200% bonds due July 26, 2022, issued by the Province…

Davis Polk advised the representatives of the several underwriters in connection with the $103.5 million initial public offering of common stock of Kala Pharmaceuticals, Inc. The…

Davis Polk advised the joint book-running managers in connection with the $86.3 million initial public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on…

Davis Polk advised the underwriters in connection with the offering of $500 million aggregate principal amount of 1.625% U.S. dollar bonds due 2020 issued by Export Development Canada. The…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 2.250% bonds due May 18, 2022, issued by the Province of Ontario. The Davis…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 2.000% U.S. dollar bonds due 2022 issued by Export Development Canada…